These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 6777803

  • 1. Endogenous depression and imipramine levels in the blood.
    Costa D, Predescu V, Vişan-Ionescu I, Ciurezu T.
    Psychopharmacology (Berl); 1980; 70(3):291-4. PubMed ID: 6777803
    [Abstract] [Full Text] [Related]

  • 2. Imipramine blood levels and clinical outcome.
    Rigal JG, Albin HC, Duchier AR, D'Aulnay JM, Fenelon JH, Vincon GA, Demotes-Mainard FM.
    J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
    [Abstract] [Full Text] [Related]

  • 3. Comparative clinical evaluation of lofepramine and imipramine. Pharmacological aspects.
    Siwers B, Borg S, d'Elia G, Lundin G, Forshell GP, Raotma H, Román G.
    Acta Psychiatr Scand; 1977 Jan; 55(1):21-31. PubMed ID: 320828
    [Abstract] [Full Text] [Related]

  • 4. Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder: a preliminary report.
    Puig-Antich J, Perel JM, Lupatkin W, Chambers WJ, Shea C, Tabrizi MA, Stiller RL.
    J Am Acad Child Psychiatry; 1979 Jan; 18(4):616-27. PubMed ID: 541469
    [No Abstract] [Full Text] [Related]

  • 5. Clinical implications of imipramine plasma levels for depressive illness.
    Glassman AH, Perel JM, Shostak M, Kantor SJ, Fleiss JL.
    Arch Gen Psychiatry; 1977 Feb; 34(2):197-204. PubMed ID: 843179
    [Abstract] [Full Text] [Related]

  • 6. Plasma levels and antidepressive effect of imipramine.
    Gram LF, Reisby N, Ibsen I, Nagy A, Dencker SJ, Bech P, Petersen GO, Christiansen J.
    Clin Pharmacol Ther; 1976 Mar; 19(3):318-24. PubMed ID: 770049
    [Abstract] [Full Text] [Related]

  • 7. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH, Weller EB, Weller RA.
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [Abstract] [Full Text] [Related]

  • 8. Correlation between plasma and cerebrospinal levels of imipramine.
    Sathananthan GL, Gershon S, Almeida M, Spector N, Spector S.
    Arch Gen Psychiatry; 1976 Sep; 33(9):1109-10. PubMed ID: 962493
    [Abstract] [Full Text] [Related]

  • 9. Targeting imipramine dose in children with depression.
    Sallee F, Stiller R, Perel J, Rancurello M.
    Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
    [Abstract] [Full Text] [Related]

  • 10. The electroencephalographic and psychological effects of imipramine in depressed inpatients.
    Bhanji S, Lader M.
    Eur J Clin Pharmacol; 1977 Dec 16; 12(5):349-54. PubMed ID: 598406
    [Abstract] [Full Text] [Related]

  • 11. The relationship of imipramine plasma levels and verbalized hostility in nondelusional endogenous depressives.
    Natale M.
    J Nerv Ment Dis; 1979 Oct 16; 167(10):620-5. PubMed ID: 490149
    [No Abstract] [Full Text] [Related]

  • 12. [Variations in the blood levels of imipramine and desmethylimipramine, depending upon the route of administration, intramuscular or oral, of Tofranil].
    Rigal J, Albin H, França X, Vinçon G, Démotes-Mainard F.
    Ann Med Psychol (Paris); 1988 Oct 16; 146(8):764-72. PubMed ID: 3242402
    [No Abstract] [Full Text] [Related]

  • 13. [Plasma levels of imipramine and desmethylimipramine and antidepressant effect during controlled therapy(author's transl)].
    Oliver-Marti n R, Buschsenschultz E, Pichot P, Boissier J.
    Psychopharmacologia; 1975 Oct 16; 41(2):187-95. PubMed ID: 1153607
    [Abstract] [Full Text] [Related]

  • 14. Combined treatment with imipramine and mianserin. A controlled pilot study.
    Lauritzen L, Clemmesen L, Klysner R, Loldrup D, Lunde M, Schaumburg E, Waarst S, Bech P.
    Pharmacopsychiatry; 1992 Jul 16; 25(4):182-6. PubMed ID: 1528957
    [Abstract] [Full Text] [Related]

  • 15. The effects of hypnotics on imipramine treatment.
    Ballinger BR, Presly A, Reid AH, Stevenson IH.
    Psychopharmacologia; 1974 Jul 16; 39(3):267-74. PubMed ID: 4427993
    [No Abstract] [Full Text] [Related]

  • 16. Plasma levels of imipramine in depression. Environmental and genetic factors.
    Perel JM, Mendlewicz J, Shostak M, Kantor SJ, Glassman AH.
    Neuropsychobiology; 1976 Jul 16; 2(4):193-202. PubMed ID: 1012454
    [Abstract] [Full Text] [Related]

  • 17. Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose data.
    Brunswick DJ, Amsterdam JD, Mendels J, Stern SL.
    Clin Pharmacol Ther; 1979 May 16; 25(5 Pt 1):605-10. PubMed ID: 436362
    [Abstract] [Full Text] [Related]

  • 18. Quantitative determination of imipramine and desmethylimipramine in human plasma by mass fragmentography.
    Pantarott C, Belvedere G, Frigerio A.
    Z Klin Chem Klin Biochem; 1974 May 16; 12(5):224-5. PubMed ID: 4440110
    [No Abstract] [Full Text] [Related]

  • 19. Gas chromatographic-mass fragmentographic determation of "steady-state" plasma levels of imipramine and desipramine in chronically treated patients.
    Belvedere G, Burti L, Frigerio A, Pantarotto C.
    J Chromatogr; 1975 Sep 03; 111(2):313-21. PubMed ID: 1159010
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic effects of imipramine are counteracted by its metabolite, desipramine, in patients with generalized anxiety disorder.
    McLeod DR, Hoehn-Saric R, Porges SW, Kowalski PA, Clark CM.
    J Clin Psychopharmacol; 2000 Dec 03; 20(6):615-21. PubMed ID: 11106132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.